One of these polymorphisms, rs1205, has been studied together with IL-6 and IFN-α with respect to the impact of these potential regulators of CRP levels in SLE, revealing lower CRP levels in patients with IFNα activation and/or the CRP-lowering polymorphism rs1205 (Figure 1). Here, IFNA1 is linked to systemic lupus erythematosus.